• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一位药理学家回顾与展望青光眼的医学治疗

A pharmacologist looks at medical treatment in glaucoma--in retrospect and in prospect.

作者信息

Bárány E H

出版信息

Ophthalmology. 1979 Jan;86(1):80-94. doi: 10.1016/s0161-6420(79)35548-8.

DOI:10.1016/s0161-6420(79)35548-8
PMID:119200
Abstract

The histochemical distribution of carbonic anhydrase activity in the ciliary processes is shown. There is a multiplicity of possible points of attack of carbonic anhydrase inhibitors, We do not know which sites are critically inhibited at clinical dosage. One primary mechanism of the therapeutic action of miotics is ciliary muscle contraction, but on prolonged treatment, subsensitivity of the muscle may shift emphasis to miotic inhibition of aqueous secretion by unknown mechanisms. The trabecular meshwork is a slow tissue living off the aqueous. Aqueous composition in chronic simple glaucoma should therefore be studied with a view to possible treatment of the sick meshwork.

摘要

显示了睫状体中碳酸酐酶活性的组织化学分布。碳酸酐酶抑制剂有多种可能的作用靶点,我们不知道在临床剂量下哪些位点受到关键抑制。缩瞳剂治疗作用的一个主要机制是睫状肌收缩,但长期治疗后,肌肉的敏感性降低可能会将重点转移到通过未知机制抑制房水分泌的缩瞳作用上。小梁网是一种依赖房水生存的缓慢组织。因此,对于慢性单纯性青光眼患者,应该研究房水成分,以期对病变的小梁网进行可能的治疗。

相似文献

1
A pharmacologist looks at medical treatment in glaucoma--in retrospect and in prospect.一位药理学家回顾与展望青光眼的医学治疗
Ophthalmology. 1979 Jan;86(1):80-94. doi: 10.1016/s0161-6420(79)35548-8.
2
L-662,583 is a topically effective ocular hypotensive carbonic anhydrase inhibitor in experimental animals.L-662,583是一种在实验动物中具有局部降眼压作用的碳酸酐酶抑制剂。
Br J Pharmacol. 1990 Jan;99(1):59-64. doi: 10.1111/j.1476-5381.1990.tb14654.x.
3
Management of glaucoma.青光眼的治疗
Ther Hung. 1971;19(4):139-41.
4
[Effect of carbonic anhydrase inhibitor, benzanilamide, on activity of carbonic anhidrase in the ciliary body and intraocular pressure of glaucomatous eyes].[碳酸酐酶抑制剂苯甲酰胺对青光眼患者睫状体中碳酸酐酶活性及眼压的影响]
Nihon Ganka Kiyo. 1971 Sep;22(9):736-46.
5
Identification of isoenzyme C as the principal carbonic anhydrase in human ciliary processes.
Invest Ophthalmol Vis Sci. 1979 Aug;18(8):867-70.
6
Principles of medical management in chronic open angle glaucoma.慢性开角型青光眼的医学管理原则
Ann Ophthalmol. 1971 Jun;3(6):579-86.
7
Controversies in Glaucoma: Current Medical Treatment and Drug Development.青光眼的争议:当前的医学治疗与药物研发
Curr Pharm Des. 2015;21(32):4673-81. doi: 10.2174/1381612821666150909095553.
8
The modern treatment of glaucoma.青光眼的现代治疗方法。
Br J Physiol Opt. 1965;22(3):133-42.
9
[Aceclidine, a new pressure descreasing miotic. Pharmacological and Clinical studies].
Arzneimittelforschung. 1968 Mar;18(3):322-4.
10
[Enzyme-histochemical studies on the intraocular carbonic anhydrase and other enzymes in normal and corticosteroid-treated rabbits (author's transl)].正常及皮质类固醇治疗兔眼内碳酸酐酶及其他酶的酶组织化学研究(作者译)
Nippon Ganka Gakkai Zasshi. 1977 Aug 10;81(8):1019-29.

引用本文的文献

1
Unconventional aqueous humor outflow: A review.非常规房水流出:综述
Exp Eye Res. 2017 May;158:94-111. doi: 10.1016/j.exer.2016.01.017. Epub 2016 Feb 2.
2
Muscarinic subsensitivity without receptor change in monkey ciliary muscle.猴睫状肌中无受体改变的毒蕈碱敏感性降低
Br J Pharmacol. 1985 Jan;84(1):193-8.